News

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...
There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Professor of Public Health Grant Scofield joins Emile Donovan to discuss the effectiveness of Wegovy and Ozempic, and whether ...